Concepedia
Statistics
Publications
5
Citations
193
H-Index
Active since
2016
Affiliations
Natera (United States)(Current)
Erik Spickard is an author at Natera (United States).
Publications per year
2016–2024
Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial
Y.L. Verschoor, Joris van de Haar, José G. van den Berg et al. · Nature Medicine · 2024 · 93 citations · Full text
Transorganogenesis and transdifferentiation in C. elegans are dependent on differentiated cell identity
Misty R. Riddle, Erik Spickard, Angela R. Jevince et al. · Developmental Biology · 2016 · 30 citations · Full text
Association of personalized and tumor-informed ctDNA with patient survival outcomes in pancreatic adenocarcinoma
Gregory P. Botta, Maen Abdelrahim, Ronald Drengler et al. · The Oncologist · 2024 · 29 citations · Full text
Monitoring response to neoadjuvant chemotherapy in triple negative breast cancer using circulating tumor DNA
Jennifer Chen, Sridevi Addanki, Dhruvajyoti Roy et al. · BMC Cancer · 2024 · 22 citations · Full text
Circulating tumor DNA status and dynamics predict recurrence in patients with resected extrahepatic cholangiocarcinoma
Changhoon Yoo, Hyehyun Jeong, Jae Ho Jeong et al. · Journal of Hepatology · 2024 · 19 citations · Full text
1–5 of 5